Medication Safety Watch: Updates from USP

Description

Don’t miss these recent revisions from the U.S. Pharmacopeial Convention (USP). Attend this session for detailed updates on the key requirements in USP General Chapters <795> and <797> and mitigating risks associated with handling hazardous drugs in USP General Chapter <800>. USP <795> focuses on nonsterile compound formulations, while USP <797> addresses sterile preparations. 

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Review key personnel and environmental requirements when compounding nonsterile preparations.
  2. Explain risk management strategies for handling hazardous drugs, including those in U.S. Pharmacopeial Convention (USP) General Chapter <800>.
  3. Discuss the revision process for USP <797> and how it will synchronize with USP <800>.

 

Technician Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Review key personnel and environmental requirements when compounding nonsterile preparations.
  2. Explain risk management strategies for handling hazardous drugs, including those in U.S. Pharmacopeial Convention (USP) General Chapter <800>.
  3. Discuss the revision process for USP <797> and how it will synchronize with USP <800>.

 

 
 
 
Speakers:
Ryan
Ryan Forrey,
 
Patricia
Patricia Kienle,
Director/Chief Pharmacist
Cardinal Health
 
Learning Level: Level 2
Pathway: Meeting Highlights Video on Demand
Track: Pharmacy Management and Professional Leadership
Session Time Slot(s): 
Date: 
Sunday, March 26
Time: 
3:30 PM - 5:30 PM
Room: 
Moscone - Esplanade 301
ACPE Pharmacist: 0202-0000-17-071-L05-P
CEUs Pharmacist: .2
ACPE Pharmacy Technician: 0202-0000-17-071-L05-T
CEUs Pharmacy Technician: .2
Activity Type:
Knowledge-based